C12N15/113 - page 28 - CPC Classification Index

#8101

20170100486

2017-04-13

Compounds and methods for trans-membrane delivery of molecules

#8102

20170100482

2017-04-13

Lipocationic polymers and uses thereof

#8103

20170100462

2017-04-13

Genomic instability markers in Fanconi anemia

#8104

20170100458

2017-04-13

Use of CPNE7 for differentiating non-dental mesenchymal stem cells into odontoblasts, regenerating dental pulp and treating dentin hypersensitivity

#8105

20170099813

2017-04-13

METHOD OF GENERATING STERILE TERMINAL SIRES IN LIVESTOCK AND ANIMALS PRODUCED THEREBY

#8106

20170096683

2017-04-06

AAV vectors for retinal and CNS gene therapy

#8107

20170096671

2017-04-06

MicroRNA induction of cardiac regeneration

#8108

20170096669

2017-04-06

Diagnosis and treatment of Friedreich's ataxia

#8109

20170096668

2017-04-06

Compounds and methods for enhanced cellular uptake

#8110

20170096667

2017-04-06

INHIBITING GENE EXPRESSION WITH dsRNA

#8111

20170096666

2017-04-06

METHOD OF THERAPY AND DIAGNOSIS OF ENDOTHELIAL DYSFUNCTION

#8112

20170096665

2017-04-06

Compositions and methods for inhibiting gene expression of LPA

#8113

20170096664

2017-04-06

Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences

#8114

20170096663

2017-04-06

siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis

#8115

20170096662

2017-04-06

ADMINISTERING ANTISENSE OLIGONUCLEOTIDES COMPLEMENTARY TO HUMAN APOLIPOPROTEIN B

#8116

20170096517

2017-04-06

Diblock copolymers and polynucleotide complexes thereof for delivery into cells

#8117

20170096486

2017-04-06

AGENTS INHIBITING GRANULIN FOR TREATMENT OF CANCER

#8118

20170088857

2017-03-30

Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling

#8119

20170088838

2017-03-30

Compositions and methods for controlling arthropod parasite and pest infestations

#8120

20170088837

2017-03-30

Methods for enhancing or decreasing the levels of MIR124 and MIR29 in subjects with muscular dystrophy

#8121

20170088836

2017-03-30

TREATMENT AND PREVENTION OF ADRENOCORTICAL CARCINOMA

#8122

20170088835

2017-03-30

COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING

#8123

20170088834

2017-03-30

MicroRNA composition for the treatment of neuroblastoma

#8124

20170088619

2017-03-30

Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells

#8125

20170087087

2017-03-30

Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites

#8126

20170083675

2017-03-23

Method for Selecting Patient Subpopulation for Custirsen Treatment

#8127

20170082611

2017-03-23

Methods for Inhibiting Epithelial to Mesenchymal Transition by Inhibition of FOXS1

#8128

20170081670

2017-03-23

Methods for modulating KLHL1 levels, methods for modulating current activity in T-type calcium channels, molecules therefor, and methods for identifying molecules therefor

#8129

20170081663

2017-03-23

Retinoid-lipid drug carrier

#8130

20170081662

2017-03-23

COMPOUNDS, COMPOSITION, METHODS, TARGETS FOR CANCER THERAPY

#8131

20170081661

2017-03-23

Cell penetrating peptides for intracellular delivery of molecules

#8132

20170081660

2017-03-23

Oligonucleic acid variant libraries and synthesis thereof

#8133

20170081425

2017-03-23

Peptide containing conjugates for dual molecular delivery of oligonucleotides

#8134

20170080107

2017-03-23

Allele selective gene editing and uses thereof

#8135

20170080099

2017-03-23

Carrier nanoparticles and related compositions, methods and systems

#8136

20170080095

2017-03-23

COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES

#8137

20170079920

2017-03-23

Technology for the Preparation of Microparticles

#8138

20170073768

2017-03-16

Individualized cancer therapy

#8139

20170073683

2017-03-16

Nucleic acid fragment binding to target protein

#8140

20170073681

2017-03-16

RNAi-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma

#8141

20170073680

2017-03-16

Treatment of Collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene

#8142

20170073679

2017-03-16

Compositions and Methods for Selective Delivery of Oligonucleotide Molecules to Cell Types

#8143

20170073678

2017-03-16

Organic compositions to treat HSF1-related diseases

#8144

20170073677

2017-03-16

TREATMENT OF MULTIPLE SCLEROSIS BY INHIBITION OF ALLOGRAFT INFLAMMATORY FACTOR-1

#8145

20170073676

2017-03-16

Treatment for conditions associated with fibrosis and collagen deposition

#8146

20170073675

2017-03-16

RNA sequence having anti-tumour activity

#8147

20170073674

2017-03-16

CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa

#8148

20170071208

2017-03-16

COMPOSITIONS FOR MOSQUITO CONTROL AND USES OF SAME

#8149

20170067115

2017-03-09

MiR-320e and colorectal cancer

#8150

20170067105

2017-03-09

Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome

#8151

20170067076

2017-03-09

Invertebrate microRNAs

#8152

20170067056

2017-03-09

RNA interference in dermal and fibrotic indications

#8153

20170067054

2017-03-09

Skin and hair color-controlling factor

#8154

20170067053

2017-03-09

Methods for preventing and treating chronic kidney disease (CKD)

#8155

20170067052

2017-03-09

Antisense nucleic acids

#8156

20170067051

2017-03-09

Targeting microRNAs for metabolic disorders

#8157

20170067050

2017-03-09

RNA-interference by single-stranded RNA molecules

#8158

20170067049

2017-03-09

MicroRNAs 206 and 21 cooperate to promote RAS-extracellular signal-regulated kinase signaling by suppressing the translation of RASA1 and SPRED1

#8159

20170067048

2017-03-09

Antisense nucleic acids

#8160

20170067021

2017-03-09

Modified cells and methods of therapy

#8161

20170067018

2017-03-09

Reprogramming of human wharton's jelly cells to produce hair cells

#8162

20170065724

2017-03-09

Metal-particle-based oral-administrating liver-specific nucleic acid delivery system and method of manufacturing the same

#8163

20170065636

2017-03-09

Modified cells and methods of therapy

#8164

20170058307

2017-03-02

Eukaryotic cells and methods for recombinantly expressing a product of interest

#8165

20170058298

2017-03-02

Compounds and methods for CRISPR/Cas-based genome editing by homologous recombination

#8166

20170058278

2017-03-02

COMPOSITIONS AND METHODS OF USING SAME FOR CONTROLLING PATHOGENICALLY INFECTED MOSQUITOES

#8167

20170056515

2017-03-02

Compositions and methods for transport across the blood brain barrier

#8168

20170051352

2017-02-23

Methods of treating autoimmune conditions in patients with genetic variations in DcR3 or in a DcR3 network gene

#8169

20170051310

2017-02-23

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#8170

20170051291

2017-02-23

RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders

#8171

20170051288

2017-02-23

Methods for treating cancer using nucleic acids targeting MDM2 or MYCN

#8172

20170051286

2017-02-23

METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT

#8173

20170051285

2017-02-23

COMPOSITIONS AND METHODS OF USING SAME FOR REDUCING RESISTANCE TO MOSQUITO LARVICIDES

#8174

20170051284

2017-02-23

Manipulating microRNA for the management of neurological diseases or conditions and compositions related thereto

#8175

20170051283

2017-02-23

RNA interference for the treatment of gain-of-function disorders

#8176

20170051282

2017-02-23

EXTRACELLULAR VESICLE METHODS AND COMPOSITIONS

#8177

20170051281

2017-02-23

Method and composition for diagnosis or treatment of aggressive prostate cancer

#8178

20170051280

2017-02-23

Methods and compositions for inhibiting retinopathy of prematurity

#8179

20170051279

2017-02-23

VASCULAR RE-MODELLING

#8180

20170051278

2017-02-23

Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

#8181

20170051277

2017-02-23

ANTISENSE OLIGOMERS AND METHODS FOR TREATING SMN-RELATED PATHOLOGIES

#8182

20170051276

2017-02-23

Compositions and methods of nucleic acid-targeting nucleic acids

#8183

20170049897

2017-02-23

P97-polynucleotide conjugates

#8184

20170049869

2017-02-23

Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin

#8185

20170049801

2017-02-23

MULTIBLOCK COPOLYMERS

#8186

20170049800

2017-02-23

Pharmaceutical combination comprising a CIP2A silencing agent for use in the treatment of a hyperproliferative disorder, preferably one with impaired P53 function

#8187

20170049794

2017-02-23

Pdia4 protein as a target for diagnosis, monitoring and treatment of diabetes

#8188

20170049771

2017-02-23

Targeting PARP1 for treatment of TSC and cancers

#8189

20170044611

2017-02-16

Genetic alterations on chromosome 16 and methods of use thereof for the diagnosis and treatment of type 1 diabetes

#8190

20170044555

2017-02-16

Recombinant RNA particles and methods of producing proteins

#8191

20170044550

2017-02-16

Polycomb-associated non-coding RNAs

#8192

20170044544

2017-02-16

OLIGONUCLEOTIDE SPECIFIC UPTAKE OF NANOCONJUGATES

#8193

20170044543

2017-02-16

Compositions and methods to promote erythropoiesis

#8194

20170044542

2017-02-16

Plant sRNA extract or plant miRNA for use as an immunosuppressive agent

#8195

20170044541

2017-02-16

miRNAs Enhancing Cell Productivity

#8196

20170044540

2017-02-16

SARNA COMPOSITIONS AND METHODS OF USE

#8197

20170044539

2017-02-16

Oligomeric compounds comprising alpha-beta-constrained nucleic acid

#8198

20170044538

2017-02-16

Compositions and Methods for Modulation of SMN2 Splicing in a Subject

#8199

20170044537

2017-02-16

CRISPR-BASED COMPOSITIONS AND METHODS OF USE

#8200

20170044536

2017-02-16

CRISPR-based compositions and methods of use

#8201

20170044535

2017-02-16

CRISPR-based compositions and methods of use

#8202

20170044534

2017-02-16

METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOLLOWING EXONS OF THE HUMAN DUCHENNE MUSCULAR DYSTROPHY GENE: 43, 46, 50-53

#8203

20170044533

2017-02-16

Methods for the treatment of Leber congenital amaurosis

#8204

20170044532

2017-02-16

Methods for producing enteroendocrine cells that make and secrete insulin

#8205

20170044531

2017-02-16

Transposon Activation During Aging and Neuronal Decline

#8206

20170044530

2017-02-16

tRNA derived small RNAs (tsRNAs) involved in cell viability

#8207

20170044529

2017-02-16

Methods and Compositions to Modulate RNA Processing

#8208

20170044528

2017-02-16

Crosslinked nucleoside and nucleotide

#8209

20170044527

2017-02-16

2′/3′/5′-(R/S)-serinyl functionalized oligonucleotides

#8210

20170044508

2017-02-16

Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides

#8211

20170044237

2017-02-16

Antibodies and processes for preparing the same

#8212

20170043024

2017-02-16

Bioactive conjugates for oligonucleotide delivery

#8213

20170042973

2017-02-16

Compositions and methods for modulating stem cells and uses thereof

#8214

20170042931

2017-02-16

Methods targeting miR-128 for regulating cholesterol/lipid metabolism

#8215

20170042825

2017-02-16

LIPID NANO PARTICLES COMPRISING CATIONIC LIPID FOR DRUG DELIVERY SYSTEM

#8216

20170042819

2017-02-16

NANOPARTICLES FOR TARGETED GENE THERAPY AND METHODS OF USE THEREOF

#8217

20170042814

2017-02-16

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

#8218

20170037431

2017-02-09

In vivo Gene Engineering with Adenoviral Vectors

#8219

20170037411

2017-02-09

Modulation of pre-MRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease

#8220

20170037408

2017-02-09

NEAT1 as a prognostic marker and therapeutic target for prostate cancer

#8221

20170037406

2017-02-09

Pharmaceutical composition comprising Nanog shRNA, and method of using Nanog shRNA to treat cancer

#8222

20170037405

2017-02-09

LncRNAs for therapy and diagnosis of angiogenesis

#8223

20170037404

2017-02-09

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

#8224

20170037403

2017-02-09

OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN MODULATION OF SMALL NON-CODING RNAS

#8225

20170037402

2017-02-09

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#8226

20170037401

2017-02-09

COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES

#8227

20170037400

2017-02-09

MODULATING IMMUNE RESPONSES

#8228

20170037399

2017-02-09

Chiral design

#8229

20170037398

2017-02-09

Artificial mimic miRNA for controlling gene expression, and use of same

#8230

20170037397

2017-02-09

SPINAL MUSCULAR ATROPHY TREATMENT VIA TARGETING SMN2 CATALYTIC CORE

#8231

20170037396

2017-02-09

Polycomb-associated non-coding RNAs

#8232

20170037184

2017-02-09

VITAMIN E-BASED NANOCARRIERS FOR DRUG DELIVERY AND METHODS OF MAKING AND USING THE SAME

#8233

20170037118

2017-02-09

Methods for treating and/or limiting development of diabetes

#8234

20170035899

2017-02-09

Method and carrier complexes for delivering molecules to cells

#8235

20170035693

2017-02-09

Sterile Emulsion Comprising a Stable Phosphorothioate Oligonucleotide

#8236

20170029858

2017-02-02

Compositions and methods for making selenocysteine containing polypeptides

#8237

20170029850

2017-02-02

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING PRIMARY OPEN ANGLE GLAUCOMA

#8238

20170029849

2017-02-02

Recombinant virus products and methods for inhibition of expression of DUX4

#8239

20170029846

2017-02-02

Compositions and methods for controlling pests

#8240

20170029824

2017-02-02

RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)

#8241

20170029818

2017-02-02

RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy

#8242

20170029817

2017-02-02

Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

#8243

20170029816

2017-02-02

Multivalent oligonucleotide assemblies

#8244

20170029815

2017-02-02

RNAi agents modified at the 4′-C position

#8245

20170029814

2017-02-02

Agents useful in treating facioscapulohumeral muscular dystrophy

#8246

20170029448

2017-02-02

Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells

#8247

20170028074

2017-02-02

MultiLigand agent for drug delivery

#8248

20170028049

2017-02-02

Specific and unique T cell responses and molecular signatures for the treatment and diagnosis of

#8249

20170022562

2017-01-26

Biomarkers and therapeutic targets for abnormal retinal pigment epithelium

#8250

20170022518

2017-01-26

Nucleic acid molecules to control insect pests

#8251

20170022504

2017-01-26

Polycomb-associated non-coding RNAs

#8252

20170022500

2017-01-26

Targeting molecule and a use thereof

#8253

20170022499

2017-01-26

METHODS AND COMPOSITIONS FOR THE PRODUCTION OF GUIDE RNA

#8254

20170022498

2017-01-26

METHOD OF REGULATING GENE EXPRESSION

#8255

20170022497

2017-01-26

Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo

#8256

20170022496

2017-01-26

Avian influenza virus miRNA, and appraisal, detection, and application thereof

#8257

20170022495

2017-01-26

REDUCTION OF OFF-TARGET RNA INTERFERENCE TOXICITY

#8258

20170021030

2017-01-26

Asymmetric bifunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents

#8259

20170021018

2017-01-26

Combination therapy for the treatment of autoimmune diseases

#8260

20170020819

2017-01-26

Compositions and methods for nanoparticle lyophile forms

#8261

20170016024

2017-01-19

PRP8 NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS

#8262

20170016023

2017-01-19

SNAP25 NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS

#8263

20170016003

2017-01-19

Composition for promoting chondrocyte differentiation or treating cartilage diseases, containing KLF10 expression inhibitor, and method for promoting cartilage differentiation by using same

#8264

20170016002

2017-01-19

Method of Treating Cancer by Inhibition of DNA Repair Proteins

#8265

20170015999

2017-01-19

COMPOSITIONS AND METHODS FOR TREATMENT OF OVARIAN CANCER

#8266

20170015998

2017-01-19

Low molecular weight cationic lipids for oligonucleotide delivery

#8267

20170015997

2017-01-19

Dual targeting antisense oligonucleotides as apoptotic inhibtor therapeutic compostions and methods for their use in the treatment of cancer

#8268

20170015996

2017-01-19

Compositions and methods for treating cachexia

#8269

20170015995

2017-01-19

Compositions and methods for modulation of SMN2 splicing in a subject

#8270

20170009308

2017-01-12

Plants with useful traits and related methods

#8271

20170009306

2017-01-12

MicroRNA expression in human peripheral blood microvesicles and uses thereof

#8272

20170009248

2017-01-12

Regulatory polynucleotides and uses thereof

#8273

20170009239

2017-01-12

RNA interference in skin indications

#8274

20170009235

2017-01-12

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

#8275

20170009234

2017-01-12

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

#8276

20170009233

2017-01-12

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

#8277

20170009232

2017-01-12

Compositions and methods for inhibition of nucleic acids function

#8278

20170009231

2017-01-12

Methods used to treat cancer

#8279

20170009230

2017-01-12

COMPOSITIONS FOR INHIBITING DUX4 GENE EXPRESSION AND USES THEREOF

#8280

20170009229

2017-01-12

Inhibition of NEAT1 for treatment of solid tumors

#8281

20170009228

2017-01-12

BIOLOGICAL MATERIALS AND THERAPEUTIC USES THEREOF

#8282

20170009211

2017-01-12

DOWNREGULATION OF miR-7 FOR PROMOTION OF BETA CELL DIFFERENTIATION AND INSULIN PRODUCTION

#8283

20170007702

2017-01-12

Trialkyl cationic lipids and methods of use thereof

#8284

20170007666

2017-01-12

Compositions and methods for treating diabetes

#8285

20170007645

2017-01-12

Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders

#8286

20170004254

2017-01-05

Multi-targeting short interfering RNAs

#8287

20170002379

2017-01-05

Synthetic genes and genetic constructs

#8288

20170002359

2017-01-05

Modulation of prekallikrein (PKK) expression

#8289

20170002358

2017-01-05

Method for treatment of heart failure

#8290

20170002354

2017-01-05

MiRNA modulators of thermogenesis

#8291

20170002353

2017-01-05

Methods and Compositions Related To miR-21 and miR-29A, Exosome Inhibition And Cancer Metastasis

#8292

20170002352

2017-01-05

Inhibitors of thioredoxin-interacting protein (TXNIP) for therapy

#8293

20170002351

2017-01-05

Compositions and methods for reducing C/EBP homologous protein activity in myeloid-derived suppressor cells

#8294

20170002350

2017-01-05

TAILED MIRTRON EFFECTORS FOR RNAI-MEDIATED GENE SILENCING

#8295

20170002349

2017-01-05

SMALL RNA, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PHARMACEUTICALS FOR SPECIFICALLY UP-REGULATING GENE TRANSCRIPTIONAL ACTIVITY

#8296

20170002348

2017-01-05

Micrornas that silence tau expression

#8297

20170002059

2017-01-05

Eukaryotic cells and methods for recombinantly expressing a product of interest

#8298

20170001950

2017-01-05

Compounds for targeting drug delivery and enhancing siRNA activity

#8299

20170000893

2017-01-05

Compounds for targeting drug delivery and enhancing siRNA activity

#8300

20170000804

2017-01-05

Methods and Compositions for Inhibiting Mitochondrial Trafficking

#8301

20160376606

2016-12-29

Identification and use of target genes for control of plant parasitic nematodes

#8302

20160376598

2016-12-29

Polycomb-associated non-coding RNAS

#8303

20160376592

2016-12-29

Methods of Manipulating the Fate of Cells

#8304

20160376591

2016-12-29

iRNA agents with biocleavable tethers

#8305

20160376590

2016-12-29

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#8306

20160376589

2016-12-29

Micro-RNA inhibitor

#8307

20160376588

2016-12-29

Molecular re-engineering of excitation-inhibition balance in memory circuits

#8308

20160376587

2016-12-29

Functionally-modified oligonucleotides and subunits thereof

#8309

20160376586

2016-12-29

Nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interferencde in eukaryotic host and use of the nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG repeats

#8310

20160376585

2016-12-29

Oligonucleotide-ligand conjugates and process for their preparation

#8311

20160376323

2016-12-29

Adeno-associated virus virions with variant capsid and methods of use thereof

#8312

20160376296

2016-12-29

Biocompatible flavonoid compounds for organelle and cell imaging

#8313

20160376224

2016-12-29

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

#8314

20160375151

2016-12-29

Adeno-associated virus virions with variant capsid and methods of use thereof

#8315

20160375143

2016-12-29

MIKTO-ARM BRANCHED POLYMERS

#8316

20160375094

2016-12-29

TYROSINE-PHOSPHORYLATED WBP2, A NOVEL CANCER TARGET AND BIOMARKER

#8317

20160369296

2016-12-22

Parental RNAI suppression of kruppel gene to control hemipteran pests

#8318

20160369282

2016-12-22

COMPOSITIONS FOR BACTERIAL MEDIATED GENE SILENCING AND METHODS OF USING SAME

#8319

20160369280

2016-12-22

Double-stranded and single-stranded RNA molecules with 5′ triphosphates and their use for inducing interferon

#8320

20160369278

2016-12-22

RNAi targeting CNTD2

#8321

20160369277

2016-12-22

Antisense polynucleotides to induce exon skipping and methods of treating dystrophies

#8322

20160369276

2016-12-22

RNAi targeting ZNF205

#8323

20160369275

2016-12-22

Modulation of transthyretin expression

#8324

20160369274

2016-12-22

THERAPEUTIC AND DIAGNOSTIC STRATEGIES

#8325

20160369273

2016-12-22

Compositions and their uses directed to huntingtin

#8326

20160369272

2016-12-22

COMPOSITIONS AND METHODS FOR DELIVERING MICRORNA

#8327

20160369271

2016-12-22

METHODS OF USING STRUCTURALLY INTERACTING RNA

#8328

20160369270

2016-12-22

Inhibition of microRNA-134 for the treatment of seizure-related disorders and neurologic injuries

#8329

20160369269

2016-12-22

Polycation-functionalized nanoporous silicon carrier for systemic delivery of gene silencing agents

#8330

20160367701

2016-12-22

Compositions for in vivo expression of therapeutic sequences in the microbiome

#8331

20160367628

2016-12-22

Molecular marker for cancer stem cell

#8332

20160362695

2016-12-15

Methods and compositions for neuroprotection

#8333

20160362690

2016-12-15

Polynucleotides and methods for inhibiting cancer cells

#8334

20160362689

2016-12-15

DIFFERENTIALLY EXPRESSED MICRORNA MOLECULES FOR THE TREATMENT AND DIAGNOSIS OF CANCER

#8335

20160362688

2016-12-15

COMPOSITIONS AND METHODS OF USING MICRORNA INHIBITORS

#8336

20160362687

2016-12-15

Methods and compositions for modulating alpha-1 antitrypsin expression

#8337

20160362686

2016-12-15

COMPOSITION INCLUDING RCC1-REGULATING SUBSTANCE FOR REDUCING SENESCENCE OF CELL OR SUBJECT AND METHOD OF REDUCING SENESCENCE OF CELL OR SUBJECT BY USING THE COMPOSITION

#8338

20160362685

2016-12-15

In vivo production of small interfering RNAs that mediate gene silencing

#8339

20160362482

2016-12-15

COMPOSITIONS AND METHODS OF MODULATING B CELL RESPONSE

#8340

20160362464

2016-12-15

Therapeutic targets for cancer progression

#8341

20160362461

2016-12-15

KIDNEY DISEASE TARGETS AND USES THEREOF

#8342

20160361340

2016-12-15

TREATMENT OF CARDIAC DISEASES WITH MODULATORS OF THE HIPPO PATHWAY

#8343

20160356775

2016-12-08

METHODS FOR CATEGORISING CANCER SUCH AS BREAST CANCER

#8344

20160355825

2016-12-08

Treatment of disease by modulation of SIRT6

#8345

20160355823

2016-12-08

Control of Varroa mite infestation

#8346

20160355819

2016-12-08

Potent LNA oligonucleotides for the inhibition of HIF-1A expression

#8347

20160355818

2016-12-08

METHOD OF FIXING AND EXPRESSING PHYSIOLOGICALLY ACTIVE SUBSTANCE

#8348

20160355817

2016-12-08

RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases

#8349

20160355816

2016-12-08

PROKARYOTIC RNAi-LIKE SYSTEM AND METHODS OF USE

#8350

20160355815

2016-12-08

miR-29 mimics and uses thereof

#8351

20160355814

2016-12-08

miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)

#8352

20160355813

2016-12-08

Polycomb-associated non-coding RNAs

#8353

20160355812

2016-12-08

Compositions and methods for treating liver injury

#8354

20160355811

2016-12-08

Antisense oligonucleotides for treatment of spinal muscular atrophy

#8355

20160355810

2016-12-08

Modulation of Exon Recognition in Pre-mRNA By Interfering with the Secondary RNA Structure

#8356

20160355809

2016-12-08

MicroRNA-Based Methods and Assays for Osteosarcoma

#8357

20160355808

2016-12-08

Oligonucleotide compounds for targeting huntingtin mRNA

#8358

20160355807

2016-12-08

THERAPEUTIC AND DIAGNOSTIC MOLECULES

#8359

20160355806

2016-12-08

Polycomb-associated non-coding RNAs

#8360

20160355805

2016-12-08

Double stranded oligonucleotide compounds comprising positional modifications

#8361

20160355804

2016-12-08

MODULATION OF MICRORNA-138 FOR THE TREATMENT OF BONE LOSS

#8362

20160355797

2016-12-08

Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systems

#8363

20160355796

2016-12-08

Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disorders

#8364

20160354487

2016-12-08

COMPOSITIONS AND METHODS OF USE OF CRISPR-CAS SYSTEMS IN NUCLEOTIDE REPEAT DISORDERS

#8365

20160354474

2016-12-08

Anionic polyplexes for use in the delivery of nucleic acids

#8366

20160354464

2016-12-08

Compositions and methods for modulating an immune response

#8367

20160354313

2016-12-08

Hybridosomes, compositions comprising the same, processes for their production and uses thereof

#8368

20160348161

2016-12-01

Detection of nucleic acids

#8369

20160348130

2016-12-01

SPT5 NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS

#8370

20160348111

2016-12-01

Antisense design

#8371

20160348110

2016-12-01

NUCLEIC ACID CHEMICAL MODIFICATIONS

#8372

20160348109

2016-12-01

POST-SYNTHETIC CHEMICAL MODIFICATION OF RNA AT THE 2'-POSITION OF THE RIBOSE RING VIA "CLICK" CHEMISTRY

#8373

20160348108

2016-12-01

Ribozyme with tRNA synthetase activity and methods of manufacturing and using the same

#8374

20160348107

2016-12-01

Compositions and methods for inhibiting gene expression of Hif2alpha

#8375

20160348106

2016-12-01

Alternative export pathways for vector expressed RNA interference

#8376

20160348105

2016-12-01

Compounds of chemically modified oligonucleotides and methods of use thereof

#8377

20160348104

2016-12-01

Modulation of signal transducer and activator of transcription 3 (STAT3) expression

#8378

20160348103

2016-12-01

Oligonucleotides and Methods for Treatment of Cardiomyopathy Using RNA Interference

#8379

20160348102

2016-12-01

Oligonucleotides and methods for inhibiting or reducing bacterial biofilms

#8380

20160348101

2016-12-01

Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions

#8381

20160348100

2016-12-01

MODULATION OF TRANSTHYRETIN EXPRESSION

#8382

20160346311

2016-12-01

LONG NON-CODING RNA SPRY4-IT1 AS A DIAGNOSTIC AND THERAPEUTIC AGENT

#8383

20160346204

2016-12-01

Nanoscale carriers for the delivery or co-delivery of chemotherapeutics, nucleic acids and photosensitizers

#8384

20160341741

2016-11-24

SCREENING FOR TARGET-SPECIFIC AFFINITY BINDERS

#8385

20160340744

2016-11-24

miR-211 expression and related pathways in human melanoma

#8386

20160340676

2016-11-24

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#8387

20160340675

2016-11-24

MICRORNA MODULATION OF ARTHEROSCLEROSIS AND USES THEREOF

#8388

20160340674

2016-11-24

Compositions and Methods to Inhibit EZH2 for the Treatment of Cardiovascular Diseases

#8389

20160340673

2016-11-24

Methods for the prevention and the treatment of extracapillary glomerulonephritis

#8390

20160340671

2016-11-24

Clonal analysis of functional genomic assays and compositions for practicing same

#8391

20160340653

2016-11-24

Delivery of packaged RNA to mammalian cells

#8392

20160340443

2016-11-24

Multimeric Complexes with Improved in Vivo Stability, Pharmacokinetics and Efficacy

#8393

20160340426

2016-11-24

In vitro method for identifying compounds of the Nav 1.9 sodium channel intended for the treatment of an inflammatory skin disease

#8394

20160340425

2016-11-24

CANCER TARGETS AND USES THEREOF

#8395

20160339053

2016-11-24

Compositions and methods for treating autoimmune and inflammatory diseases

#8396

20160338327

2016-11-24

Metabolism-based drug screening platform in bioengineered zebrafish

#8397

20160333377

2016-11-17

Enhancing endonuclease based gene editing in primary cells

#8398

20160333353

2016-11-17

MiRNA for treating diseases and conditions associated with neo-angiogenesis

#8399

20160333352

2016-11-17

5′ triphosphate oligonucleotide with blunt end and uses thereof

#8400

20160333348

2016-11-17

Altering microbial populations and modifying microbiota